Literature DB >> 1386207

Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases.

L S Forno1.   

Abstract

Some of the similarities and differences between the neuropathology of Parkinson's disease, Huntington's disease, and Alzheimer's disease have been reviewed, and the relationship between the three diseases has been discussed. Although interconnected and reciprocally innervated structures are affected in PD and HD, they appear less closely related than in PD and AD. Different neurotoxins may play a part in their pathogenesis, as also suggested from other evidence. Neuropathologic features of PD, HD and AD are entirely compatible with a role for neurotoxins in their pathogenesis, but do not by themselves make a strong case for a neurotoxic hypothesis. However, additional neuropathologic studies of experimental neurotoxins may further strengthen arguments in favor of a neurotoxic etiology, as the MPTP animal model is doing for Parkinson's disease. Such experimental studies along with further molecular biological and other sophisticated new methods may open the way for exciting new developments in the near future.

Entities:  

Mesh:

Year:  1992        PMID: 1386207     DOI: 10.1111/j.1749-6632.1992.tb24519.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  David A Price; Alex A Martinez; Alexandre Seillier; Wouter Koek; Yolanda Acosta; Elizabeth Fernandez; Randy Strong; Beat Lutz; Giovanni Marsicano; James L Roberts; Andrea Giuffrida
Journal:  Eur J Neurosci       Date:  2009-05-21       Impact factor: 3.386

2.  A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons.

Authors:  M P Smidt; H S van Schaick; C Lanctôt; J J Tremblay; J J Cox; A A van der Kleij; G Wolterink; J Drouin; J P Burbach
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.

Authors:  Michael T Heneka; Elena Galea; Vitaliy Gavriluyk; Lucia Dumitrescu-Ozimek; JoAnna Daeschner; M Kerry O'Banion; Guy Weinberg; Thomas Klockgether; Douglas L Feinstein
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

4.  Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat.

Authors:  Sinéad Walsh; Katarzyna Mnich; Ken Mackie; Adrienne M Gorman; David P Finn; Eilís Dowd
Journal:  Brain Res Bull       Date:  2010-01-25       Impact factor: 4.077

Review 5.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

6.  5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.

Authors:  G P Reynolds; S L Mason; A Meldrum; S De Keczer; H Parnes; R M Eglen; E H Wong
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

7.  Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson's Disease: An In Situ Proximity Ligation Assay Study.

Authors:  Francesca Longhena; Gaia Faustini; Cristina Missale; Marina Pizzi; Arianna Bellucci
Journal:  Int J Mol Sci       Date:  2018-05-30       Impact factor: 5.923

8.  System biology and bioinformatics pipeline to identify comorbidities risk association: Neurodegenerative disorder case study.

Authors:  Utpala Nanda Chowdhury; Shamim Ahmad; M Babul Islam; Salem A Alyami; Julian M W Quinn; Valsamma Eapen; Mohammad Ali Moni
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

9.  The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.

Authors:  P Githure M'Angale; Brian E Staveley
Journal:  BMC Neurosci       Date:  2016-05-18       Impact factor: 3.288

Review 10.  The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention.

Authors:  Stephanie M Boas; Kathlene L Joyce; Rita M Cowell
Journal:  Antioxidants (Basel)       Date:  2021-12-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.